FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308976413> ?p ?o ?g. }

• W4308976413 endingPage "e2242048" @default.
• W4308976413 startingPage "e2242048" @default.
• W4308976413 abstract "Primary care physicians (PCPs) are significant contributors of early cancer detection, yet few studies have investigated whether consistent primary care translates to improved downstream outcomes.To evaluate the association of prediagnostic primary care use with metastatic disease at diagnosis and cancer-specific mortality (CSM).This cohort study used databases with primary care and referral linkage from multiple Veterans' Affairs centers from 2004 to 2017 and had a 68-month median follow-up. Analysis was completed between July 2021 and September 2022. Participants included veterans older than 39 years who had been diagnosed with 1 of 12 cancers. Inclusion criteria included known clinical staging, survival follow-up, cause of death, and receiving care at the Veterans Affairs health system (VA).Prediagnostic PCP use, measured in the 5 years prior to diagnosis. PCP visits were binned into none (0 visits), some (1-4 visits), and annual (5 visits).Metastatic disease at diagnosis, cancer-specific mortality (CSM) for entire cohort and stratified by tumor subtype.Among 245 425 patients representing 12 tumor subtypes, mean age was 65.8 (9.3) years, and the cohort skewed male (97.6%), and White (76.1%), with higher levels of comorbidity (58.6% with Charlson Comorbidity Index scores ≥2). Compared with no prior visit, some PCP use was associated with 26% decreased odds of metastatic disease at diagnosis (odds ratio [OR], 0.74; 95% CI, 0.71-0.76; P < .001) and 12% reduced risk of CSM (subdistribution hazard ratio [SHR], 0.88; 95% CI, 0.86-0.89; P < .001). Annual PCP use was associated with 39% decreased odds of metastatic disease (OR, 0.61; 95% CI, 0.59-0.63; P < .001) and 21% reduced risk of CSM (SHR, 0.79; 95% CI, 0.77-0.81; P < .001). Among tumor subtypes, prostate cancer had the largest effect size for prior PCP use on metastatic disease at diagnosis (OR for annual use, 0.32; 95% CI, 0.30-0.35; P < .001) and CSM (SHRfor annual use, 0.51; 95% CI, 0.48-0.55; P < .001).In this cohort study, increased primary care use before cancer diagnosis was associated with significant decreases in metastatic disease at diagnosis and cancer-related death, with potentially the greatest difference from annual use. PCPs play a vital role in cancer prevention, and additional resources should be allocated to assist these physicians." @default.
• W4308976413 created "2022-11-20" @default.
• W4308976413 creator A5000733810 @default.
• W4308976413 creator A5001121096 @default.
• W4308976413 creator A5001579411 @default.
• W4308976413 creator A5002263437 @default.
• W4308976413 creator A5004819903 @default.
• W4308976413 creator A5018618797 @default.
• W4308976413 creator A5039221785 @default.
• W4308976413 creator A5040550923 @default.
• W4308976413 creator A5044071754 @default.
• W4308976413 creator A5059026108 @default.
• W4308976413 creator A5064099533 @default.
• W4308976413 creator A5084644796 @default.
• W4308976413 creator A5089442996 @default.
• W4308976413 date "2022-11-14" @default.
• W4308976413 modified "2023-10-15" @default.
• W4308976413 title "Association Between Primary Care Use Prior to Cancer Diagnosis and Subsequent Cancer Mortality in the Veterans Affairs Health System" @default.
• W4308976413 cites W112580149 @default.
• W4308976413 cites W130099911 @default.
• W4308976413 cites W1889567604 @default.
• W4308976413 cites W1936755136 @default.
• W4308976413 cites W1966569417 @default.
• W4308976413 cites W1989976457 @default.
• W4308976413 cites W2000241906 @default.
• W4308976413 cites W2000445173 @default.
• W4308976413 cites W2036489555 @default.
• W4308976413 cites W2093829713 @default.
• W4308976413 cites W2099444409 @default.
• W4308976413 cites W2120357482 @default.
• W4308976413 cites W2128733308 @default.
• W4308976413 cites W2147579615 @default.
• W4308976413 cites W2154346058 @default.
• W4308976413 cites W2242458983 @default.
• W4308976413 cites W2433575101 @default.
• W4308976413 cites W2900081888 @default.
• W4308976413 cites W2911910338 @default.
• W4308976413 cites W2922490216 @default.
• W4308976413 cites W2983086603 @default.
• W4308976413 cites W2992183762 @default.
• W4308976413 cites W3048659619 @default.
• W4308976413 cites W3093891269 @default.
• W4308976413 cites W3200228050 @default.
• W4308976413 cites W4200382959 @default.
• W4308976413 cites W4237701866 @default.
• W4308976413 cites W4247974459 @default.
• W4308976413 cites W4251665430 @default.
• W4308976413 cites W4252688831 @default.
• W4308976413 cites W4256361436 @default.
• W4308976413 doi "https://doi.org/10.1001/jamanetworkopen.2022.42048" @default.
• W4308976413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36374497" @default.
• W4308976413 hasPublicationYear "2022" @default.
• W4308976413 type Work @default.
• W4308976413 citedByCount "1" @default.
• W4308976413 countsByYear W43089764132023 @default.
• W4308976413 crossrefType "journal-article" @default.
• W4308976413 hasAuthorship W4308976413A5000733810 @default.
• W4308976413 hasAuthorship W4308976413A5001121096 @default.
• W4308976413 hasAuthorship W4308976413A5001579411 @default.
• W4308976413 hasAuthorship W4308976413A5002263437 @default.
• W4308976413 hasAuthorship W4308976413A5004819903 @default.
• W4308976413 hasAuthorship W4308976413A5018618797 @default.
• W4308976413 hasAuthorship W4308976413A5039221785 @default.
• W4308976413 hasAuthorship W4308976413A5040550923 @default.
• W4308976413 hasAuthorship W4308976413A5044071754 @default.
• W4308976413 hasAuthorship W4308976413A5059026108 @default.
• W4308976413 hasAuthorship W4308976413A5064099533 @default.
• W4308976413 hasAuthorship W4308976413A5084644796 @default.
• W4308976413 hasAuthorship W4308976413A5089442996 @default.
• W4308976413 hasBestOaLocation W43089764131 @default.
• W4308976413 hasConcept C121608353 @default.
• W4308976413 hasConcept C126322002 @default.
• W4308976413 hasConcept C156957248 @default.
• W4308976413 hasConcept C194828623 @default.
• W4308976413 hasConcept C201903717 @default.
• W4308976413 hasConcept C207103383 @default.
• W4308976413 hasConcept C2775969662 @default.
• W4308976413 hasConcept C2776135927 @default.
• W4308976413 hasConcept C2777654188 @default.
• W4308976413 hasConcept C2779159551 @default.
• W4308976413 hasConcept C44249647 @default.
• W4308976413 hasConcept C512399662 @default.
• W4308976413 hasConcept C71924100 @default.
• W4308976413 hasConcept C72563966 @default.
• W4308976413 hasConceptScore W4308976413C121608353 @default.
• W4308976413 hasConceptScore W4308976413C126322002 @default.
• W4308976413 hasConceptScore W4308976413C156957248 @default.
• W4308976413 hasConceptScore W4308976413C194828623 @default.
• W4308976413 hasConceptScore W4308976413C201903717 @default.
• W4308976413 hasConceptScore W4308976413C207103383 @default.
• W4308976413 hasConceptScore W4308976413C2775969662 @default.
• W4308976413 hasConceptScore W4308976413C2776135927 @default.
• W4308976413 hasConceptScore W4308976413C2777654188 @default.
• W4308976413 hasConceptScore W4308976413C2779159551 @default.
• W4308976413 hasConceptScore W4308976413C44249647 @default.
• W4308976413 hasConceptScore W4308976413C512399662 @default.
• W4308976413 hasConceptScore W4308976413C71924100 @default.
• W4308976413 hasConceptScore W4308976413C72563966 @default.

• next